Indigo Acquisition (NASDAQ:INAC – Get Free Report) released its earnings results on Monday. The company reported $0.06 earnings per share (EPS) for the quarter, FiscalAI reports.
Indigo Acquisition Stock Performance
Indigo Acquisition stock opened at $10.45 on Tuesday. The stock’s 50 day moving average is $10.37 and its 200 day moving average is $10.25. Indigo Acquisition has a twelve month low of $10.01 and a twelve month high of $10.45.
Institutional Investors Weigh In On Indigo Acquisition
A hedge fund recently bought a new position in Indigo Acquisition stock. Sona Asset Management US LLC purchased a new stake in shares of Indigo Acquisition Corp. (NASDAQ:INAC – Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 158,059 shares of the company’s stock, valued at approximately $1,611,000. Sona Asset Management US LLC owned approximately 1.23% of Indigo Acquisition at the end of the most recent reporting period.
Analyst Upgrades and Downgrades
Check Out Our Latest Analysis on INAC
About Indigo Acquisition
Indigo Acquisition Corp. is a special purpose acquisition company (SPAC) organized to identify and complete a business combination with an operating company. Its potential transaction could take the form of a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination.
Unlike an operating company, Indigo Acquisition Corp. does not appear to have established products, services or significant commercial operations of its own. Its activities are primarily focused on evaluating prospective acquisition targets and pursuing a transaction that would allow a target business to become publicly traded.
Publicly available information provides limited detail about the company’s target industry, geographic markets and leadership beyond its acquisition-focused structure.
Further Reading
- Five stocks we like better than Indigo Acquisition
- SpaceX Starlink’s Telecom Ground Game Takes Shape
- AST SpaceMobile’s Brazil Breakthrough Could Set the Stage for a Q3 Stock Rebound
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
Receive News & Ratings for Indigo Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indigo Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
